Ilama VHH as a Substitute for Rabbit Polyclonal Antibodies in ELISpot Application
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411881 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chloé Reynas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diaclone SAS-Part of Medix Biochemica Group, 6 Rue Dr Jean-François-Xavier Girod, 25000 Besançon, France. Hauptthemen laut MEDLINE: Enzyme-Linked Immunospot Assay, Camelids, New World, Antibodies, Single-Domain Antibodies. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enzyme-Linked-Immunosorbent-Spot (ELISpot) is a highly sensitive technique capable of detecting low-level immune responses, offering critical insights into therapy-induced immune activation. Our mouse interferon-gamma (mIFN-γ) ELISpot assay was originally based on a monoclonal capture antibody and a rabbit polyclonal detection antibody. The objective of our study was to replace the polyclonal detection antibody with a monoclonal alternative, using a llama immune library and phage display technology. A llama was immunized with recombinant mIFN-γ, and an immune VHH library was constructed. The library underwent two rounds of panning using the recombinant antigen. Subsequently, 190 clones were screened by Enzyme-Linked-Immunosorbent Assay (ELISA), yielding 27 specific binders to mIFN-γ. Sequence analysis revealed 24 unique clones grouped into four families based on their CDR3-VH sequences. One representative clone from each family was reformatted as VHH-Human Fragment Crystallizable (VHH-hFc) fusion and produced recombinantly for testing in the ELISpot assay. The purified candidates were evaluated in pairs on native mIFN-γ from mouse splenocytes. Two candidates, H3 and G4, were selected for further trial. Comparative analysis of ELISpot performance showed that G4 is a promising substitute for the original rabbit polyclonal antibody, enhancing the overall performance of the mIFN-γ ELISpot assay. This study highlights the potential of VHH antibodies in ELISpot applications and supports their use as a robust, reproducible alternative to polyclonal antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diaclone SAS-Part of Medix Biochemica Group, 6 Rue Dr Jean-François-Xavier Girod, 25000 Besançon, France.
ORCID-Profile: Pierre-Emmanuel Baurand
Zitieren
APA
Reynas, C., Balland, J., Simonin, H., & Baurand, P. E. (2025). Ilama VHH as a Substitute for Rabbit Polyclonal Antibodies in ELISpot Application. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411881
Vancouver
Reynas C, Balland J, Simonin H, Baurand PE. Ilama VHH as a Substitute for Rabbit Polyclonal Antibodies in ELISpot Application. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411881
BibTeX
@article{Reynas2025,
author = {Reynas, Chloé and Balland, Jérémy and Simonin, Harmonie and Baurand, Pierre-Emmanuel},
title = {Ilama VHH as a Substitute for Rabbit Polyclonal Antibodies in ELISpot Application},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411881}
}
EUVIMED